Citation Information :
Rath D, Tomar DS, Khodiar PK, Patra PK. Evaluation of Serum Electrolytes in Sickle Cell Disease Patients with Respect to Hydroxyurea Therapy. Indian J Med Biochem 2019; 23 (1):182-184.
Background: Sickle cell disease is one of the oldest genetic disorders known to medical science. The morbidity and mortality associated with the disease and its complication, sickle cell crisis, amounts to be a significant health issue. Hydroxyurea, originally used as an anticancer agent, has proved to be the wonder drug in lower doeses in sickle cell diease. The severity and impact of the disease on the affected person is decreased by a great extent by its use. The mechanism of action of the drug in sickle cell disease is yet to be completely understood. Electrolytes play a crucial role in the pathophysiology of sickle cell disease.
Aim: The current study aims to evaluate the serum electrolyte levels in sickle cell disease patients and look for the effect of hydroxyurea on them.
Materials and methods: Fifty two sickle cell disease (SS) patients and 20 normal individuals were included in the study (AA). Thirty four of the SS patients were under hydroxyurea therapy. The serum levels of magnesium, sodium, potassium, chloride, calcium, phosphate were estimated in all the study subjects.
Results and discussion: No significant difference was found with respect to the serum electrolytes in the sickle cell patients under and not under hydroxyurea therapy. But the serum electrolytes varied significantly between the sickle cell disease patients and the normal individuals.
Conclusion: Serum electrolytes play a crucial role in the pathophysiology of sickle cell disease, but hydroxyuera therapy does not seem to play a great role in altering their levels in the patients.
Dong Cheng, Chadwick R, Schechter A.Hemoglobin and membrane in sickle cell deformability. Biophysical Journal. 1992;63 (3):774-783.
Rao Janardhan M, Iyer S, Acharya S. Polymerization of Hemoglobin S. The Journal of Biological Chemistry. 1995;270 (33):19250-19255.
Samuel C, Michael T, Richard M, George D, Franca B, Susan E, Robert M, Duane B. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. The New England Journal of Medicine. 1995;332(20):1317-1322.
Winfred W., Suzette O, Zhaoyu L, Sheree B, Scott M, James C, Billie F, Bruce T, Scott G. Hydroxyurea Is Associated With Lower Costs of Care of Young Children With Sickle Cell Anemia. American Academy of Pediatrics. 2013;132(4):677-683.
Madan K, Sudhindra M, Nilima T, Sachin K, Nilesh R. Evaluation of Saliva as Biochemical Indicator for Electrolyte Estimation in Sickle Cell Anemic Patients. Journal of Pharmacy and Biological Sciences. 2016;11(4):05-08.
Agoreyo F, Nwanze N. Plasma sodium and potassium changes in sickle cell patients. International Journal of Genetics and Molecular Biology. 2010; 2(2):14-19.
Ataga K, Smith W, De Castro L, Swerdlow P., Saunthararajah Y, Castro O, Vichinsky E, Kutlar A, Orringer E, Rigdon G, Stocker J. Phase 2 Senicapoc study in Sickle Cell Anemia. The American Society of Hematology. 2008;111(8): 3991-3997.
Brugnara C, Gee B, Armsby C, Kurth S, Sakamato M, Rifai R, Alper S, Platt O. Clotrimazole and Sickle Cell Anemia. The American Society for Clinical Investigation. 1996; 97(2):12271234.
Meshram Ajay W, Bhatkulkar Priyanka A, Khare R, Pazare K. Hematological indices in Sickle Cell Disease. International Journal of Medical Science and Public Health. 2014; 3(11): 1410-1412.
Pandey S, Sharma A, Dahia S, Shah V, Sharma V, Mishra R, Pandey SW, Saxena R. Biochemical Indicator of Sickle Cell Disease. Indian Journal of Clinical Biochemistry. 2012; 27(2): 191-195.
Clark MR, Guatell JC, White AT, Shohet SB. Study of the dehydrated effect of the red cell Na+ /K+ pump in treated cells with varying Na+ and water content. Biochim Biophys Acta. 1981;646(3): 422-432.
Emokpae MA, Musa MO. Impact of fetalhemoglobin on micronutrients in sickle cell anemia. Journal of Applied Hematology. 2015; 6(2): 74-78.
Nnodim JK, Samuel M, Dioka CE, Onah CE, Ihim A, AtuegbuC. Trace elements deficiency in patients with homozy-gous sickle cell disease. British Journal of Medicine and Medical Research 2014; 4(21): 3878- 3883.
Digban AK, Okogun G, Matthew A, Jemikalajah JD. Evaluation of some micronutrients in sickle cell disease. International Journal of Innovative Research and Development. 2016; 5(8): 309-313.
Oladipo O, Temiye E, Ezeaka V, Obomanu P. Serum magnesium, phosphate and calcium in Nigerian children with Sickle Cell Disease. West African Journal of Medicine. 2015; 24(2): 120-123.